NCT04486482 - A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 12, 2021

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions

Mild-to-Moderate COVID-19

Interventions

OTHER

KB109 + Self Supportive Care (SSC)

KB109 is a novel glycan

OTHER

Self Supportive Care (SSC) Alone

Trial Locations (12)

Advanced Pharma CR, LLC, Miami

Hope Clinical Trials, Miami

Next Phase Research Alliance, Boca Raton

Kendall South Medical Center, Inc., Miami

Cullman Clinical Trials, Cullman

Quad Clinical Research, Chicago

Inquest Research, Baytown

Olympus Family Medicine, Salt Lake City

South Ogden Family Medicine Center, South Ogden

American Institute of Research, Los Angeles

Rancho Cucamonga Clinical Research, Rancho Cucamonga

Massachusetts General Hospital, Boston